In vitro and in vivo antitumor activity of the novel trinuclear platinum complex BBR 3464 in neuroblastoma

Cancer Chemotherapy and Pharmacology

Volumn 47, Issue 6, 2001, Pages 498-504

  Riccardi, Anna ^a   Meco, Daniela ^a   Ferlini, Cristiano ^a   Servidei, Tiziana ^a   Carelli, Giovanni ^a   Segni, Giuseppe ^a   Manzotti, Carla ^b   Riccardi, Riccardo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Novuspharma SpA   (Italy)

Author keywords

BBR 3464; Cisplatin; Neuroblastoma; Trinuclear platinum complex

Indexed keywords

BBR 3464; CISPLATIN; PLATINUM COMPLEX;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG DNA BINDING; DRUG EFFICACY; DRUG POTENCY; MALE; MITOSIS INHIBITION; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CISPLATIN; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MICE; MICE, NUDE; NEUROBLASTOMA; ORGANOPLATINUM COMPOUNDS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0035024213     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800000264     Document Type: Article

References (13)

1. 1. Brabec V, Kasparkova J, Vrana O, Novakova O, Cox JW, Qu Y, Farrell N (1999) DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent. Biochemistry 38(21):6781
2. 2. Brown JM, Wouters BG (1999) Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res 59:1391
3. 3. Calvert PM, Hughes A, Azzabi A, Verrill M, Camboni G, Verdi E, Bernareggi A, Zucchetti M, Minoia C, Sessa C, Carmichael J, Calvert AH (2000) Phase I clinical and pharmacokinetic study of BBR 3464, a novel bifunctional platinum analogue, in patients with advanced solid tumours (abstract). Proc Am Soc Clin Oncol 19:921F
4. 4. Cooper MJ, Hutchins GM, Cohen PS, Helman LJ, Israel MA (1991) Neuroblastoma cell lines mimic chromaffin neuroblastoma maturation. Prog Clin Biol Res 366:343
5. 5. Evans AE, D'Angio GJ, Propert K, Andersen J, Hann HW (1987) Prognostic factors in neuroblastoma. Cancer 59:1853
6. 6. Ferlini C, Di Cesare S, Rainaldi G, Malorni W, Samoggia P, Biselli R, Fattorossi A (1996) A flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques. Cytometry 24:106
7. 7. Kelland LR, Murrer BA, Abel G, Giandomenico CM, Mistry P, Harrap KR (1992) Ammine/amine platinum (IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines. Cancer Res 52:822
8. 8. Manzotti C, Pratesi G, Menta E, Di Domenico R, Cavalletti E, Fiebig HH, Kelland LR, Farrell N, Polizzi D, Supino R, Pezzoni G, Zunino F (2000) BBR 3464: a novel triplatinum complex exhibiting a preclinical profile of antitumor efficacy different from cisplatin. Clin Cancer Res 6:2626
9. 9. Perego P, Zunino F, Carenini N, Giuliani F, Spinelli S, Howell SB (1998) Sensitivity to cisplatin and platinum-containing compounds of Schizosaccharomyces plombe rad mutans. Mol Pharmacol 54:213
10. 10. Perego P, Caserini C, Gatti L, Carenini N, Romanelli S, Supino R, Colangelo D, Viano I, Leone R, Spinelli S, Pezzoni G, Manzotti C, Farrell N, Zunino F (1999) A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system. Mol Pharmacol 55:528
11. 11. Pratesi G, De Cesare M, Caserini C, Perego P, Dal Bo L, Polizzi D, Supino R, Bigioni M, Manzini S, Iafrate E, Salvatore C, Casazza A, Arcamone F, Zunino F (1998) Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenografts. Clin Cancer Res 4:2833
12. 12. Pratesi G, Perego P, Polizzi D, Righetti SC, Supino R, Caserini C, Manzotti C, Giuliani FC, Pezzoni G, Tognella S, Spinelli S, Farrell N, Zunino F (1999) A novel trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts. Br J Cancer 80:1912
13. 13. Stram DO, Matthay KK, O'Leary M, Reynols CP, Haase GM, Atkinson JB, Brodeur GM, Seeger RC (1996) Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent children's cancer group studies. J Clin Oncol 14:2417